Subtitle
Cost effectiveness
Subtitle
Cost effectiveness
Proto therapy Time
February 2016
Executive summary
A systematic review of the cost-effectiveness of proton therapy found that proton therapy was a cost-effective option for several pediatric brain tumors, selected left-sided breast cancer, selected head and neck cancer and locoregionally advanced non-small cell lung cancer.
Top cancer treatments
Related contents
Proton Therapy Publication
April 2024
Comprehensive radiotherapy for pediatric Ewing Sarcoma: Outcomes of a prospective proton study.
en
Proton Therapy Publication
May 2023
Outcomes of Patients Treated in the UK Proton Overseas Programme: Non-central Nervous System Group.
en
Proton Therapy Publication
January and February 2023
Comparison of neurocognitive and quality-of-life outcomes in pediatric craniopharyngioma patients treated with partial resection and radiotherapy versus gross-total resection only.
en
Proton Therapy Publication
January and February 2023
Efficacy and safety of proton beam therapy for rhabdomyosarcoma: a systematic review and metaanalysis.
en
Webinar
November 7, 2023
Tumeurs pédiatriques: L'apport de la proton thérapie - Partie 4/4
Alejandro
Mazal
Webinar
November 7, 2023
Tumeurs pédiatriques: L'apport de la proton thérapie - Partie 3/4
Stephanie
Bolle
Webinar
November 7, 2023
Pediatric tumors: Added value of Proton Therapy - Part 2/4
Srinivas
Chilukuri
en
Webinar
November 7, 2023
Tumeurs pédiatriques: L'apport de la proton thérapie - Partie 1/4
Jean-Louis
Habrand
Proton Therapy Publication
September 2023
Surgery and proton radiation therapy for pediatric base of skull chordomas: Long-term clinical outcomes for 204 patients.
en